Hormone receptor positive (ER+/PR+)
Gene: ESR1 · Type: expression
Indications: Breast cancer
FDA Sensitivity Assertions
| Drug | Indication | Recommendation | FDA Source | Link |
|---|---|---|---|---|
| Anastrozole | Breast cancer | INDICATED | FDA Label | |
| Letrozole | Breast cancer | INDICATED | FDA Label | |
| Exemestane | Breast cancer | INDICATED | FDA Label | |
| Tamoxifen | Breast cancer | INDICATED | FDA Label | |
| Fulvestrant | Breast cancer | INDICATED | FDA Label | |
| Toremifene | Breast cancer | INDICATED | FDA Label | |
| Palbociclib | Breast cancer | INDICATED | FDA Label | |
| Ribociclib | Breast cancer | INDICATED | FDA Label | |
| Abemaciclib | Breast cancer | INDICATED | FDA Label | |
| Elacestrant | Breast cancer | INDICATED | FDA Label |